ResApp needs to demonstrate to the FDA that the probable benefits of the device outweigh its probable risks
Today's announcement and feedback from these 65 GP's will help with that decision.
Regards
Bloky
ResApp needs to demonstrate to the FDA that the probable...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #